DRFZ versus SARS-CoV2
At the Leibniz Institute German Rheumatism Research Center Berlin, interdisciplinary scientists investigate the basics of immunity and autoimmunity, i.e. the difference between protective and harmful immune reactions. The DRFZ is one of the world’s leading research institutes in the fields of antibody-producing plasma cells and B lymphocytes, innate lymphocytes, T lymphocytes and immunological memory, i.e. long-term immunity. Unique technologies for research on immune reactions have been developed here. This expertise is now offered for research on SARS-CoV2 immunity and immunopathology, in collaboration with virological and clinical research groups.
SARS-CoV2 is a challenge for everyone
Here is an overview of the DRFZ’s technological expertise, a unique arsenal for the diagnosis of Covid-19 immunity and the generation of monoclonal antibodies against SARS-Cov2:
- Platforms for identification, isolation, analysis and use of single human immune cells from blood and tissue (fluorescence-based and mass cytometry, fluorescence-based and magnetic cell sorting (MACS technology))
- The DRFZ has developed worldwide unique methods for the identification of inflammation-associated monocytes (Siglec-1), virus-specific NK cells, reactive T lymphocytes (ARTE technology), reactive B lymphocytes and plasma cells (HLA-DR).
- Platform for global investigation of such cells on single-cell level (single-cell omics, CITE-Seq, antigen receptor repertoire, bioinformatics)
Contact at the DRFZ
The Corona virus and our immune system
Prof. Andreas Radbruch explains how exactly the corona virus affects the body, which type of drug search would probably be the fastest and what can be learned from corona cases in China and Australia in a podcast initiated by the Leibniz Association and t-online.de in conversation with moderator Ursula Weidenfeld:
Podcast: Tonspur Wissen – Corona-Questions to Andreas Radbruch
The outbreak and spread of the coronavirus changes the whole life. Many people have questions, scientists can provide answers – and from now on they will do so every day in the podcast “Tonspur Wissen”.